Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- 205 Principles of antibiotic therapy
- 206 Antibacterial agents
- 207 Antifungal therapy
- 208 Antiviral therapy
- 209 Probiotics
- 210 Hypersensitivity to antibiotics
- 211 Antimicrobial agent tables
- Index
- References
209 - Probiotics
from Part XXV - Antimicrobial therapy: general considerations
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- 205 Principles of antibiotic therapy
- 206 Antibacterial agents
- 207 Antifungal therapy
- 208 Antiviral therapy
- 209 Probiotics
- 210 Hypersensitivity to antibiotics
- 211 Antimicrobial agent tables
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 1366 - 1370Publisher: Cambridge University PressPrint publication year: 2015
References
, , , et al. Prevention and treatment of urinary tract infection with probiotics: review and research perspective. Indian J Urol. 2008;24(2):139–144.CrossRefGoogle ScholarPubMed
, , , . Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations. Int J Food Microbiol. 1997;35:1–27.CrossRefGoogle ScholarPubMed
, . Clinical indications for probiotics: an overview. Clin Infect Dis. 2008;46:S96–S100.CrossRefGoogle ScholarPubMed
, . Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients. 2013;5(1):58–81. .CrossRefGoogle ScholarPubMed
, , , et al. Probiotics in primary prevention of atopic disease: a randomised placebo control trial. Lancet. 2001;357:1076–1079.CrossRefGoogle Scholar
, . Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol. 2010;300:25–33.CrossRefGoogle ScholarPubMed
, , , et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80(Suppl 1):S147–S171.CrossRefGoogle ScholarPubMed
, , , et al. Demonstration of safety of probiotics: a review. Int J Food Microbiol. 1998;44:93–106.CrossRefGoogle ScholarPubMed
, . Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol. 2009;15(1):81–85.Google Scholar